Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
lung cancer
MedTech
IceCure's treatment may extend survival in lung cancer patients
IceCure is touting a new study showing its procedure combined with radiation may extend survival for patients with an inoperable form of lung cancer.
Natalie Missakian
Nov 6, 2025 5:30am
Fierce Pharma
Editor's Corner—Summit must submit to Big Pharma, stat
Sep 10, 2025 2:50pm
BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC
Sep 8, 2025 11:00am
Fierce Pharma
Summit's global PD-1xVEGF data show new promising OS trend
Sep 7, 2025 3:30am
Galvanize nets $100M, and a new CEO, to bring PFA to lung cancer
Sep 4, 2025 1:00pm
Oric lays off 20% of workforce in focus on clinical-stage drugs
Aug 13, 2025 6:20am